Feprazone

• CAT Number: R041665
• CAS Number: 30748-29-9
• Molecular Formula: C20H20N2O2
• Molecular Weight: 320.39
• Purity: ≥95%
• Synonyms: 4-(3-Methyl-2-buten-1-yl)-1,2-diphenyl-3,5-pyrazolidinedione; 4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione; 4-Prenyl-1,2-diphenyl-3,5-dioxopyrazolidine; 4-Prenyl-1,2-diphenyl-3,5-pyrazolidinedione; Analud; DA 2370; Fenilprenazone; Methra
• Target: NF-κB
• Storage: Store at -20C
• IUPAC Name: 4-(3-methylbut-2-enyl)-1,2-diphenylpyrazolidine-3,5-dione
• InChI: InChI=1S/C20H20N2O2/c1-15(2)13-14-18-19(23)21(16-9-5-3-6-10-16)22(20(18)24)17-11-7-4-8-12-17/h3-13,18H,14H2,1-2H3
• InChIKey: RBBWCVQDXDFISW-UHFFFAOYSA-N
• SMILES: CC(=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)C

Feprazone(CAT: R041665) is a non-steroidal anti-inflammatory drug (NSAID) belonging to the pyrazolone class. It is primarily used to treat pain and inflammation associated with conditions such as arthritis, gout, and musculoskeletal disorders. Feprazone works by inhibiting the cyclooxygenase (COX) enzymes, which play a key role in the production of prostaglandins, mediators of pain and inflammation. In addition to its anti-inflammatory effects, Feprazone exhibits analgesic and antipyretic properties. While effective in managing inflammation, it is important to monitor for potential side effects, including gastrointestinal discomfort and, in rare cases, blood dyscrasias associated with long-term use.